Drugs & Targets FDA Grants Orphan Designation To Reolysin for Malignant Glioma May 01, 2015Vol.41 No.17
Drugs & Targets FDA Updates Zytiga Label To Include Chemotherapy-Naive Metastatic CRPC Data April 30, 2015Vol.38 No.04
Drugs & TargetsFree Immunocore and MedImmune enter into second collaboration April 17, 2015Vol.41 No.15
Drugs & TargetsFree Bayer HealthCare expands global clinical development of copanlisib April 17, 2015Vol.41 No.15
Drugs & TargetsFree Vectibix Gets European Approval for Wild-Type RAS Colon Cancer April 10, 2015Vol.41 No.14
Drugs & TargetsFree Merck and Pfizer will begin co-promoting Xalkori in eight countries April 10, 2015Vol.41 No.14
Drugs & TargetsFree Rubicon Genomics Inc. extends its clinical supply agreement with Agendia April 10, 2015Vol.41 No.14
Drugs & TargetsFree Intrexon Corp. signs cooperative research and development agreement with NCI April 10, 2015Vol.41 No.14
Drugs & Targets Intrexon Corporation and Merck Serono to collaborate on CAR-T cancer therapies April 03, 2015Vol.41 No.13
